Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HIV-1 viral load blips are of limited clinical significance

13 Mar 2006

Abstract excerpt

Many patients on highly active antiretroviral therapy (HAART) who achieve undetectable HIV-1 RNA levels experience transient episodes of detectable viraemia or blips, suggesting there is incomplete suppression of viral replication. This raises concern that drug resistance mutations could develop and cause eventual treatment failure. However, data from recent studies indicate that most blips are actually random...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to HIV/AIDS drug development and treatment
Share to HIV/AIDS Research and Interventions
Share to HIV Research and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 16533823
DOI: 10.1093/jac/dkl092

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HIV-1 viral load blips are of limited clinical significancePMID 16533823Read ↗

Transient rebounds of HIV plasma viremia are associated with the emergence of drug resistance mutations in patients on highly active antiretroviral therapy.Semantic proximity Read ↗

Significance and clinical management of persistent low-level viremia and very-low-level viremia in HIV-1-infected patients.Semantic proximity Read ↗

Genotypic Analysis of HIV‐1 Drug Resistance at the Limit of Detection: Virus Production without Evolution in Treated Adults with Undetectable HIV LoadsSemantic proximity Read ↗

Persistent low-Level viremia in persons living with HIV undertreatment: An unresolved status.Semantic proximity Read ↗

Increased Frequency of HIV-1 Viral Load Blip Rate Observed After Switching From Roche Cobas Amplicor to Cobas Taqman AssaySemantic proximity Read ↗

How relevant is the HIV low level viremia and how is its management changing in the era of modern ART? A large cohort analysis.Semantic proximity Read ↗

Comparison of the rate and size of HIV-1 viral load blips with Roche COBAS TaqMan HIV-1 versions 1.0 and 2.0 and implications for patient management.Semantic proximity Read ↗

HIV-1-specific CD4+ T cell responses in chronically HIV-1 infected blippers on antiretroviral therapy in relation to viral replication following treatment interruption.Semantic proximity Read ↗

Comparative Performances of HIV-1 RNA Load Assays at Low Viral Load Levels: Results of an International CollaborationSemantic proximity Read ↗

Viral load monitoring: shifting paradigms in clinical practice.Semantic proximity Read ↗

Glancing behind virus load variation in HIV-1 infection.Semantic proximity Read ↗

Transient relapses ("blips") of plasma HIV RNA levels during HAART are associated with drug resistance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.